459 related articles for article (PubMed ID: 20015155)
1. Macromolecular drug transport into the brain using targeted therapy.
Lichota J; Skjørringe T; Thomsen LB; Moos T
J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
[TBL] [Abstract][Full Text] [Related]
2. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
3. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
4. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
5. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons.
Kleine TO; Benes L
Cytometry A; 2006 Mar; 69(3):147-51. PubMed ID: 16479603
[TBL] [Abstract][Full Text] [Related]
6. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
7. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.
Ganta S; Deshpande D; Korde A; Amiji M
Mol Membr Biol; 2010 Oct; 27(7):260-73. PubMed ID: 20929336
[TBL] [Abstract][Full Text] [Related]
8. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
Vlieghe P; Khrestchatisky M
Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
[TBL] [Abstract][Full Text] [Related]
9. Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.
Shen DD; Artru AA; Adkison KK
Adv Drug Deliv Rev; 2004 Oct; 56(12):1825-57. PubMed ID: 15381336
[TBL] [Abstract][Full Text] [Related]
10. Drug targeting to the brain.
de Boer AG; Gaillard PJ
Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
[TBL] [Abstract][Full Text] [Related]
11. [The blood-brain barrier. II. Physiological data].
Lefauconnier JM; Hauw JJ
Rev Neurol (Paris); 1984; 140(1):3-13. PubMed ID: 6364292
[TBL] [Abstract][Full Text] [Related]
12. [The blood-brain barrier and drug delivery in the central nervous system].
Loch-Neckel G; Koepp J
Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
[TBL] [Abstract][Full Text] [Related]
13. Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport.
Yang J; Aschner M
Neurotoxicology; 2003 Aug; 24(4-5):741-5. PubMed ID: 12900088
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier and treatment of central nervous system tumors.
Wiranowska M
J Fla Med Assoc; 1992 Oct; 79(10):707-10. PubMed ID: 1460453
[TBL] [Abstract][Full Text] [Related]
15. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
Gabathuler R
Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
Allen DD; Geldenhuys WJ
Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
[TBL] [Abstract][Full Text] [Related]
17. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
Strazielle N; Khuth ST; Ghersi-Egea JF
Adv Drug Deliv Rev; 2004 Oct; 56(12):1717-40. PubMed ID: 15381331
[TBL] [Abstract][Full Text] [Related]
18. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
19. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.
Lee G; Dallas S; Hong M; Bendayan R
Pharmacol Rev; 2001 Dec; 53(4):569-96. PubMed ID: 11734619
[TBL] [Abstract][Full Text] [Related]
20. Peptide and peptide analog transport systems at the blood-CSF barrier.
Smith DE; Johanson CE; Keep RF
Adv Drug Deliv Rev; 2004 Oct; 56(12):1765-91. PubMed ID: 15381333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
